A Once-in-a-Decade Investment Opportunity: 1 Pharmaceutical Stock to Buy Now Hand Over Fist and Hold for YearsThe Motley Fool • 10/16/25
CEOs of Wells Fargo and Pfizer caution the U.S. could lose its edge to China without innovationCNBC • 10/15/25
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks With Over 3% Dividend YieldsBenzinga • 10/15/25
TUKYSA Combination Significantly Improves Progression-Free Survival as First-Line Maintenance in HER2+ Metastatic Breast Cancer in HER2CLIMB-05 TrialBusiness Wire • 10/14/25
Pfizer to Highlight Advancements in Respiratory Health and Infectious Disease Research at IDWeek 2025Business Wire • 10/13/25
IP Group shares climb 9% on potential royalties from Pfizer's $7.3bn Metsera dealProactive Investors • 10/13/25
4 Dividend Stocks to Double Up on Right Now -- Including United Parcel Service and PfizerThe Motley Fool • 10/12/25
Here's How This Pharmaceutical Giant Is Protecting Itself From President Trump's Tariffs. Should It Matter to Investors?The Motley Fool • 10/10/25
Wilsey Discloses $2.9 Million Purchase of Pfizer Stock Amid Landmark Trump DealThe Motley Fool • 10/09/25
Here's What to Expect From Pfizer's Oncology Drugs in Q3 EarningsZacks Investment Research • 10/08/25
Will Pfizer (PFE) Beat Estimates Again in Its Next Earnings Report? (Revised)Zacks Investment Research • 10/07/25